Medtronic Says No Increased Risk of Blood Clots On Early Cessation of Dual Antiplatelet Therapy

Loading...
Loading...
Interrupting dual antiplatelet therapy after 30 days following the implantation of a Resolute drug-eluting stent from Medtronic, Inc.
MDT
caused no increase in rates of stent thrombosis at one year, according to a new analysis of the global RESOLUTE clinical program presented today at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...